A note from MedCity News on our platform capability during Covid-19

During this challenging time, MedCity News is here for the healthcare ecosystem. We’ve provided an overview of our capabilities across the editorial and sales sides of the business.

At MedCity News we have built a name for ourselves as a must-read online publication that highlights innovation across the healthcare landscape. At no time in our 11-year history is that more important than now, as life science, health tech, medtech and healthcare organizations race against time to develop treatments for Covid-19, produce much needed equipment to hospitals to support patients, and protect their staff.  

Our news team and contributors have worked diligently to report new developments to our readers but there is much more news than we can cover. Our readership of 420,000+ per month is very engaged and keen to hear what members of the healthcare industry are doing to address Covid-19 from care coordination, telemedicine, drug development, diagnostics, digital health, data analytics, population health, and more. 

The coronavirus has taken a heavy toll on companies that rely on events and face to face interactions to do business. In this new reality, the media have a particularly critical role to play. For companies interested in getting important developments for their business in front of our audience, for lead generation to thought leadership, MedCity is well-positioned to amplify your news with a readership spanning the healthcare ecosystem, which is very engaged in learning about these developments. Our newsletter and firewall-free news stories are easily accessible and found through Google, social media, and our widely distributed newsletter. 

During this difficult time, we are offering special rates on advertising and sponsored content, whether you want to promote a white paper, a virtual event, a thought leadership post, an executive interview or customized content. MedCity is here for the healthcare industry. 

Alaric DeArment, our senior biopharma reporter, and Elise Reuter, our health tech reporter, are leading the way on our news team, led by Arundhati Parmar, the editor in chief. You can reach them at [email protected], [email protected], and [email protected].

If you have experts that are interested in doing podcasts, custom content, sponsored posts, or interested in sponsoring research, please contact Stephanie Baum, director of special projects, at [email protected]. For advertising inquiries, please contact sales director Mary Aikoriegie at [email protected] .